The invention discloses a pharmaceutical composition for treating post-traumatic brain syndrome. The pharmaceutical composition is characterized by being prepared from the following materials: szechuan lovage
rhizome,
bark of oriental variegated coralbean,
rhizome of Japanese galangal, radix achyranthis bidentatae, cowherb seed, thickleaf
croton root,
flos rosae rugosae, root of lemonfragrant ostericum,
rhizome et radix notopterygii, radix angelicae pubescentis,
photinia serrulata, seed of calyx-shaped carrierea, grassleaf sweelflag rhizome,
flos chrysanthemi, uncariae ramulus cum uncis,
radix bupleuri, succvinum amber, sargentgloryvine stem, dahurian
patrinia herb, plantain seed, sweet wormwood
herb, root of straight ladybel, cortex lycii, fructus lycii,
semen cuscutae, radix astragali, radix
ginseng rubra, radix angelicae sinensis and radix notoginseng. Brain collateral injure, a post-traumatic brain syndrome, causes
blood stasis and
weakness, and thus endogenous wind and exogenous wind seize the opportunity to get in; pathogenic wind blocks collaterals to cause pathogenic factors to block meridians, and thus causes exuberance of deficiency-heat; qi and blood are unsmooth to cause
blood stasis, depression causes heat, and the
pathogenesis is
blood stasis, qi stagnation, blood stasis on head, qi-blood deficiency, and deficiency of
liver and kidney. According to the invention, removing blood stasis and wind, promoting qi circulation, removing obstruction in collaterals, inducing
resuscitation, promoting
blood circulation, enriching blood and qi, soothing nerves, tonifying deficiency, nourishing
liver and kidney, and tonifying brains are taken as rules of treatment so as to achieve the purpose of treating post-traumatic brain syndrome.